- Psychemedics Corporation (PMD, Financial) unveils its 2025 Workforce Insights Report highlighting significant drug testing trends in the workplace.
- Healthcare and manufacturing sectors have the highest positive drug test rates, at 14.7% and 14.6% respectively.
- States with legalized marijuana show a 10% increase in workplace injuries among young workers.
Psychemedics Corporation (PMD) has released its 2025 Workforce Insights Report, shedding light on critical trends in workplace drug testing derived from the analysis of hundreds of thousands of hair samples collected in 2024. The report uncovers worrying developments including a rise in synthetic opioids such as fentanyl and nitazenes, known for their extreme potency.
The healthcare and manufacturing industries exhibit the highest positive drug test rates, at 14.7% and 14.6% respectively. Additionally, states that have legalized marijuana report a 10% rise in workplace injuries among young workers, posing new challenges for employers in these regions.
Psychemedics' hair testing method stands out for its 90-day detection window and strong resistance to evasion, offering a reliable solution for long-term drug detection. CEO Brian Hullinger emphasizes the increasing challenges employers face in ensuring safe workplaces amid evolving drug threats and legislative changes.
This comprehensive report equips employers with the necessary insights to adapt policies, reduce liability, and make informed decisions. It positions Psychemedics strategically in the growing employment screening market, supporting its leadership in the sector. For more detailed insights, the full report is available on the company's website.
